S. İRKİN Et Al. , "Paradoxically Psoriasis, developed in a patient using adalimumab for ankylosing spondylitis: Case report," CUMHURİYET MEDICAL JOURNAL , vol.43, no.2, pp.177-181, 2021
İRKİN, S. Et Al. 2021. Paradoxically Psoriasis, developed in a patient using adalimumab for ankylosing spondylitis: Case report. CUMHURİYET MEDICAL JOURNAL , vol.43, no.2 , 177-181.
İRKİN, S., ÇABUK ÇELİK, N., KARAKAŞ, B., KARATAŞ, B., & ŞAHİN, A., (2021). Paradoxically Psoriasis, developed in a patient using adalimumab for ankylosing spondylitis: Case report. CUMHURİYET MEDICAL JOURNAL , vol.43, no.2, 177-181.
İRKİN, SENA Et Al. "Paradoxically Psoriasis, developed in a patient using adalimumab for ankylosing spondylitis: Case report," CUMHURİYET MEDICAL JOURNAL , vol.43, no.2, 177-181, 2021
İRKİN, SENA Et Al. "Paradoxically Psoriasis, developed in a patient using adalimumab for ankylosing spondylitis: Case report." CUMHURİYET MEDICAL JOURNAL , vol.43, no.2, pp.177-181, 2021
İRKİN, S. Et Al. (2021) . "Paradoxically Psoriasis, developed in a patient using adalimumab for ankylosing spondylitis: Case report." CUMHURİYET MEDICAL JOURNAL , vol.43, no.2, pp.177-181.
@article{article, author={SENA İRKİN Et Al. }, title={Paradoxically Psoriasis, developed in a patient using adalimumab for ankylosing spondylitis: Case report}, journal={CUMHURİYET MEDICAL JOURNAL}, year=2021, pages={177-181} }